Armata Pharmaceuticals, Inc. — Director's Dealing 2005

Nov 2, 2005

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TARGETED GENETICS CORP /WA/ (TGEN)
CIK: 0000921114
Period of Report: 2005-11-01

Reporting Person: PERRY MICHAEL S (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2005-11-01	Stock Option (right to buy)	$0.61	A	60000	Acquired	2015-11-01	Common Stock (60000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	0	Direct

Footnotes

F1: Such option vests and is exercisable as follows: 33.33% on each of November 1, 2006, 2007 and 2008.

F2: Price is not applicable.